

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Donanemab iyikhambi elisha elenzelwe ukunciphisa ukuqhubeka kwesifo i-Alzheimer ezigabeni zaso zokuqala. Lokhu kwelashwa okusha kusebenza ngokugxila nasekususeni ama-plaque e-amyloid ebuchosheni, okukholelwa ukuthi adlala indima enkulu ekuthuthukisweni kwe-Alzheimer. Nakuba kungelona ikhambi, i-donanemab inikeza ithemba elisha kubantu ababhekene nalesi simo esiyinselele ngokwazi ukusiza ukugcina inkumbulo namakhono okucabanga isikhathi eside.
I-Donanemab iyikhambi le-monoclonal antibody elenzelwe ngqo ukulwa nesifo i-Alzheimer. Cabanga ngayo njengokwelashwa okugxilwe kuso okufuna futhi kuhlasele izakhi zamaprotheni eziyingozi ebuchosheni bakho ezibizwa ngokuthi ama-plaque e-amyloid. Lezi zinhlobo ezinamathelayo ziqongelela phakathi kwamaseli obuchopho futhi kucatshangwa ukuthi ziphazamisa ukusebenza okujwayelekile kobuchopho.
Umuthi ungowesigaba esisha sokwelashwa kwe-Alzheimer esibizwa ngokuthi ama-anti-amyloid therapies. Ngokungafani nemithi yendabuko ye-Alzheimer elawula kuphela izimpawu, i-donanemab empeleni iqondisa lokho abacwaningi abakholelwa ukuthi kungenye yezimbangela eziyisisekelo zesifo. Lokhu kumelela ushintsho olukhulu endleleni esisondela ngayo ekwelashweni kwe-Alzheimer.
I-Donanemab inikezwa nge-intravenous infusion, okusho ukuthi uzoyithola ngokuqondile egazini lakho ngomugqa we-IV. Ukwelashwa kuvame ukunikezwa esikhungweni sezempilo lapho ochwepheshe bezokwelapha bengakuqapha eduze ngesikhathi nangemva kokufakwa ngakunye.
I-Donanemab ivunyelwe ngokuqondile ukwelapha ukukhubazeka okuncane kokuqonda kanye nokuwohloka kwengqondo okuncane okubangelwa isifo i-Alzheimer. Yenzelwe abantu abasezigabeni zokuqala zesimo lapho izimpawu ziqala nje ukuphazamisa impilo yansuku zonke. Umuthi usebenza kahle kakhulu lapho i-Alzheimer ibanjwa ekuqaleni, ngaphambi kokuthi kwenzeke umonakalo omkhulu ebuchosheni.
Udktora wakho uzoqoka i-donanemab kuphela uma izivivinyo ziqinisekisa ukuthi une-amyloid plaques ebuchosheni bakho. Lokhu ngokuvamile kuhilela ukuskena kobuchopho okukhethekile noma izivivinyo zoketshezi lomgogodla ezingathola lezi zinto zamaprotheni. Ukuba khona kwala ma-plaques kubalulekile ngoba umuthi uqondiswe ngqo kuwo.
Kubalulekile ukuqonda ukuthi i-donanemab ayinconyelwe abantu abanesifo i-Alzheimer's esithuthuke kakhulu. Ucwaningo lubonisa ukuthi umuthi usebenza kahle kakhulu lapho umsebenzi wobuchopho usasebenza kahle, okumnika ithuba elingcono lokunciphisa ukwehla okuqhubekayo.
I-Donanemab isebenza njengesistimu eqondiswe ngokunembile ekhomba futhi isuse ama-amyloid plaques ayingozi ebuchosheni bakho. Umuthi uqukethe ama-antibody aklanywe ngokukhethekile aqaphela lezi zinto zamaprotheni futhi aziqokele ukususwa yi-immune system yakho. Le nqubo isiza ukususa ukwakheka okunamathelayo okuphazamisa ukuxhumana kwamaseli obuchopho.
Umuthi uthathwa njengokwelashwa okuphakathi nendawo kwe-Alzheimer's disease. Ngenkathi inamandla kunezidakamizwa zokulawula izimpawu zendabuko, isebenza kancane kancane ngokuhamba kwesikhathi kunokuthi inikeze izinguquko ezinkulu ngokushesha. Abantu abaningi baqaphela ukuthuthuka okuncane ekugcineni amakhono abo amanje kunokuba bahlangabezane nokululama okukhulu.
Izifundo zomtholampilo zibonisa ukuthi i-donanemab inganciphisa ukwehla kokuqonda ngamaphesenti angaba ngu-22% uma kuqhathaniswa ne-placebo. Lokhu kusho ukuthi ungase ugcine izinga lakho lamanje lokucabanga namakhono okukhumbula izinyanga ezimbalwa ezengeziwe, okukunika isikhathi esiningi esihle nabathandekayo bakho futhi ugcine ukuzimela isikhathi eside.
I-Donanemab inikezwa njenge-infusion ye-intravenous njalo emavikini amane endaweni yokunakekelwa kwezempilo. Iseshini ngayinye yokwelashwa ihlala cishe imizuzu engama-30, lapho umuthi unikezwa kancane kancane ngomugqa we-IV engalweni yakho. Uzodinga ukuhlela isikhathi esengeziwe ngaphambi nangemva kwe-infusion yokulungiselela nokuqapha.
Ngaphambi kokwelashwa ngakunye, akudingeki ukuthi ugweme ukudla noma ulandele imikhawulo ekhethekile yokudla. Nokho, kuyasiza ukudla ukudla okulula ngaphambi kwalokho ukuvimbela noma yikuphi ukungakhululeki ngesikhathi sokufakwa. Qiniseka ukuthi unamanzi ngokwanele ngokuphuza amanzi amaningi emahoreni ngaphambi kokuqokwa kwakho.
Ithimba lakho lezempilo lizokuqapha eduze ngesikhathi sokufakwa ngakunye nangokungenani ihora ngemuva kwalokho. Bazohlola izimpawu zakho ezibalulekile futhi baqaphele noma yiziphi izimpendulo ngokushesha. Kuyajwayelekile ukuzizwa ukhathele ngemuva kokwelashwa, ngakho-ke cabanga ukuba nomuntu ozokuqhuba ekhaya emaseshini akho okuqala.
Uzodinga futhi ukuhlolwa kwe-MRI yobuchopho njalo ngesikhathi sokwelashwa kwakho ukuqapha umphumela ongase ube khona obizwa ngokuthi ukuvuvukala kobuchopho. Lokhu kuhlolwa kusiza udokotela wakho ukuthi aqinisekise ukuthi imithi isebenza ngokuphepha futhi ilungise uhlelo lwakho lokwelashwa uma kudingeka.
Abantu abaningi bathatha i-donanemab cishe izinyanga eziyi-12 kuya kweziyi-18, nakuba isikhathi esiqondile sincike ekutheni usabela kahle kangakanani ekwelashweni. Udokotela wakho uzoqapha inqubekela phambili yakho ngokuhlolwa okuvamile kokuqonda kanye nokuhlolwa kobuchopho ukuze anqume ubude bokwelashwa obufanele. Umgomo uwukuthola ukususwa okuphezulu kwe-plaque ngenkathi kunciphisa izingozi ezingaba khona.
Abanye abantu bangase bakwazi ukuyeka ukwelashwa ngokushesha uma ukuhlolwa kobuchopho kubonisa ukuncipha okukhulu kwe-plaque. Abanye bangase bazuze ekuqhubekeni nokwelashwa isikhathi esiphelele esinconyiwe. Impendulo yakho ngamunye emuthini izoqondisa lezi zinqumo, futhi udokotela wakho uzoxoxa ngendlela engcono kakhulu esekelwe esimweni sakho esithile.
Ngemuva kokuqeda ukwelashwa, uzoqhubeka nokuqokwa okuvamile kokulandela ukuqapha ukusebenza kwakho kokuqonda. Ngenkathi imiphumela yomuthi ingase iqhubeke isikhathi esithile ngemuva kokuyeka, udokotela wakho angase ancome ezinye izindlela zokwelapha ukusiza ukugcina amakhono akho okuqonda.
Ukuqonda imiphumela engase ibe khona emzimbeni kungakusiza ukuthi uzizwe ulungile futhi uqiniseka ngemithi yakho. Abantu abaningi bayayithola kahle i-donanemab, kodwa njengayo yonke imithi, ingabangela eminye imiphumela engathandeki esukela kokuncane kuya kokukhulu.
Imiphumela ejwayelekile ongase uyithole ihlanganisa:
Le miphumela ejwayelekile emzimbeni ngokuvamile iyalawuleka futhi ivame ukuthuthuka njengoba umzimba wakho ujwayela ukwelashwa. Ithimba lakho lezempilo lizokuqapha ngokucophelela futhi linganikeza ukunakekelwa okusekelayo uma kudingeka.
Imiphumela emibi kakhulu kodwa engavamile idinga ukunakekelwa kwezempilo ngokushesha. Lokhu kuhlanganisa:
Uma uhlangabezana nanoma yiziphi zalezi zimpawu ezinzima, xhumana nomhlinzeki wakho wezempilo ngokushesha noma funa ukunakekelwa kwezimo eziphuthumayo. Ukubona kusenesikhathi nokwelashwa kwale miphumela emibi kungavimbela izinkinga ezingathi sína.
I-Donanemab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungele yini wena. Abantu abanesifo i-Alzheimer's esithuthukile ngokuvamile abazuza kulolu hlobo lwelashwa ngoba sekonakele ubuchopho obukhulu. Umuthi usebenza kahle kakhulu uma umsebenzi wobuchopho usasebenza kahle.
Akufanele usebenzise i-donanemab uma unezici ezithile zofuzo ezikhuphula ingozi yokuvuvukala kobuchopho. Abantu abanamakhophi amabili e-gene ye-APOE4 babhekana nengozi enkulu yokuvuvukala kobuchopho okukhulu nokopha. Udokotela wakho cishe uzohlola le nguquko yofuzo ngaphambi kokuqala ukwelashwa.
Ezinye izimo ezingase zikuvimbele ukuthi usebenzise i-donanemab zihlanganisa:
Udokotela wakho uzobuyekeza umlando wakho wezokwelapha ophelele nemithi yamanje ukuze aqinisekise ukuthi i-donanemab iphephile kuwe. Lokhu kuhlola okucophelelayo kusiza ekuvikeleni izinkinga futhi kuqinisekisa ukuthi uthola ukwelashwa okufanele kakhulu.
I-Donanemab ithengiswa ngaphansi kwegama lomkhiqizo elithi Kisunla yi-Eli Lilly and Company. Uma uthola incwadi kadokotela wakho noma uyibona ibhalwe emadokhumenti ezokwelapha, ungase ubone noma yiliphi igama lisetshenziswa ngokushintshana. Zombili zibhekisela emuthini ofanayo onezithako ezisebenzayo ezifanayo nemiphumela.
Igama lomkhiqizo elithi Kisunla lakhethwa ukubonisa ithemba nokuxhumana, okuhambisana nomgomo womuthi wokusiza abantu ukuthi bagcine amakhono abo okuqonda nokuxhumana nabathandekayo babo. Ungase futhi ubone igama lobuchwepheshe elithi "donanemab-azbt" kwezinye izincwadi zezokwelapha, okubhekisela ekwakhekeni okuthile okusetshenziswe ezivivinyweni zomtholampilo.
Eminye imithi eminingi iyatholakala yokwelapha isifo i-Alzheimer, nakuba isebenza ngezindlela ezihlukile kune-donanemab. I-Lecanemab (Leqembi) iyindlela efana kakhulu, njengoba nayo iqondise ama-amyloid plaques ebuchosheni. Njenge-donanemab, inikezwa nge-IV infusion futhi ivunyelwe isifo i-Alzheimer esigabeni sokuqala.
Imithi yendabuko ye-Alzheimer ihlanganisa i-donepezil (Aricept), i-rivastigmine (Exelon), kanye ne-galantamine (Razadyne). Le mithi isebenza ngokwandisa amakhemikhali athile ebuchosheni kunokususa ama-plaques. Zivame ukusetshenziselwa isifo i-Alzheimer esingesibi kakhulu futhi zingathathwa njengamaphilisi noma iziqeshana.
I-Memantine (Namenda) enye inketho, evame ukunqunywa ngesifo i-Alzheimer esiphakathi nendawo kuya kwesinzima. Isebenza ngokulawula umsebenzi wobuchopho futhi ingasetshenziswa yodwa noma ihlanganiswe neminye imithi ye-Alzheimer. Udokotela wakho uzosiza ekunqumeni ukuthi iyiphi indlela yokwelapha engcono kakhulu esimweni sakho esithile.
Kokubili i-donanemab ne-lecanemab ziyindlela yokwelapha esebenzayo yesifo i-Alzheimer sokuqala, kodwa zihlukile ngokubalulekile. I-Donanemab ingase inikeze inzuzo yesikhathi sokwelashwa esifushane, ngokuvamile izinyanga eziyi-12-18 uma kuqhathaniswa nokwelashwa okuqhubekayo nge-lecanemab. Lokhu kungasho ukufakwa okuncane kanye nesikhathi esincane esichithwa ezikhungweni zokunakekelwa kwezempilo.
Izifundo zomtholampilo zikhomba ukuthi i-donanemab ingase yehlise ukwehla kokuqonda kancane kune-lecanemab, kodwa yomibili imithi ikhombisa izinzuzo eziqondakalayo. Ukukhetha phakathi kwazo kuvame ukuncika ezingozini zakho ngazinye, okuthandwa ukwelashwa, nokuthi umzimba wakho usabela kanjani emithini ngayinye.
Udktela wakho uzocabangela izinto ezinjengobunjiniyela bakho be-genetic, ezinye izimo zempilo, kanye nezintandokazi zomuntu siqu lapho enza izincomo phakathi kwalezi zinketho. Yomibili imithi idinga ukuqapha njalo futhi inezingozi ezifanayo zokuvuvukala kobuchopho nokopha, ngakho-ke isinqumo sivame ukwehla ezimweni zomuntu ngamunye kunokuthi esinye sibe ngcono ngokucacile kunomunye.
I-Donanemab ngokuvamile ingasetshenziswa ngokuphepha kubantu abanezifo zenhliziyo ezinzile, kodwa udokotela wakho wenhliziyo kanye nodokotela wezinzwa kuzodingeka basebenzisane ukuze bakuqaphe ngokucophelela. Umuthi ngokwawo awuthinti ngokuqondile ukusebenza kwenhliziyo, kodwa ukucindezeleka kokufakwa kanye nemiphumela engaba khona kungathinta abantu abanezifo zenhliziyo ezinzima.
Uma unezifo zenhliziyo, odokotela bakho cishe bazoncoma ukuqapha okwengeziwe ngesikhathi sokwelashwa. Lokhu kungabandakanya ukuhlolwa okuvame kakhulu, ukuqapha umfutho wegazi, nokunaka ngokucophelela ukuthi uzizwa kanjani ngemva kokufakwa ngakunye. Abantu abaningi abanezifo zenhliziyo ezilawulwa kahle bangathola i-donanemab ngokuphepha ngezinyathelo zokuphepha ezifanele.
Njengoba i-donanemab inikezwa endaweni yokunakekelwa kwezempilo elawulwayo, ukweqisa ngengozi akunakwenzeka. Ochwepheshe bezempilo babala ngokucophelela futhi baqaphe umthamo ngamunye ukuze baqinisekise ukuthi uthola inani eliqondile. Umuthi ulungiswa futhi unikezwe ngabasebenzi abaqeqeshiwe abalandela izinqubo zokuphepha eziqinile.
Uma ukhathazekile ngokuthola umuthi omningi ngesikhathi sokufakwa, unganqikazi ukuphakamisa. Ithimba lakho lezempilo liqapha izinga lokufakwa kanye nomthamo ophelele ngokuqhubekayo. Baqeqeshwe ukubona nokuphendula kunoma yiziphi izinkinga ezingase zivele ngesikhathi sokwelashwa.
Uma uphuthelwa ukufakwa kwakho kwe-donanemab okuhleliwe, xhumana nomhlinzeki wakho wezempilo ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Umuthi usebenza kahle kakhulu uma unikezwa ngeshejuli ejwayelekile, ngakho-ke kubalulekile ukugcina izikhawu zokwelashwa ezihambisanayo. Udokotela wakho uzosiza ekunqumeni isikhathi esingcono kakhulu sokufakwa kwakho okulandelayo.
Ungazami ukwenza ngaphezu komthamo ophuthelwe ngokuhlela ukwelashwa eduze. Lokhu kungakhuphula ingozi yakho yemiphumela emibi ngaphandle kokuhlinzeka ngezinzuzo ezengeziwe. Ithimba lakho lezempilo lizolungisa ishejuli yakho yokwelashwa ukuze ikubuyisele emgwaqeni ngokuphepha.
Ungayeka ukuthatha i-donanemab lapho udokotela wakho enquma ukuthi uzuze inzuzo enkulu ekwelashweni, ngokuvamile ngemva kwezinyanga eziyi-12-18. Isinqumo sisekelwe ekuskeneni kobuchopho obujwayelekile obukhombisa ukuthi i-amyloid plaque isusiwe kangakanani kanye nokuhlolwa kokuqonda okulinganisa amakhono akho okucabanga.
Abanye abantu bangase bakwazi ukuyeka ukwelashwa ngaphambi kwesikhathi uma ukuskena kukhombisa ukuncipha okukhulu kwe-plaque. Abanye bangazuza ekuqhubekeni nokwelashwa isikhathi esiphelele esinconyiwe. Udokotela wakho uzoxoxa ngesikhathi esingcono kakhulu esisekelwe ekuphenduleni kwakho komuntu siqu emuthini kanye nesimo sempilo esiphelele.
Kufanele ugweme ukushayela ngemva nje kokuthola i-donanemab, ikakhulukazi ngesikhathi sokwelashwa kwakho kokuqala. Umuthi ungabangela ukukhathala, isiyezi, noma ukudideka okuncane okungathinta ikhono lakho lokushayela ngokuphepha. Kungcono ukuba nomuntu okushayelayo uye futhi ubuye emaphoyintimenti akho.
Abantu abaningi bangakwazi ukuqhubeka nemisebenzi ejwayelekile, okuhlanganisa nokushayela, kungakapheli amahora angama-24 okufakwa kwabo uma bazizwa kahle. Nokho, uma uhlangabezana nanoma yimiphumela emibi eqhubekayo efana nokudideka, izinguquko zombono, noma ukukhathala okukhulu, gwema ukushayela kuze kube yilapho lezi zimpawu zixazululwa ngokuphelele. Njalo xoxa ngesimo sakho esithile nomhlinzeki wakho wezempilo.
Get clear medical guidance
on symptoms, medications, and lab reports.